NDC 62847-002

Vibativ

Telavancin Hydrochloride

Vibativ is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Theravance Biopharma R&d, Inc.. The primary component is Telavancin Hydrochloride.

Product ID62847-002_848f842a-bac0-4694-8705-24f8ba5a90fc
NDC62847-002
Product TypeHuman Prescription Drug
Proprietary NameVibativ
Generic NameTelavancin Hydrochloride
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2009-11-05
Marketing CategoryNDA / NDA
Application NumberNDA022110
Labeler NameTheravance Biopharma R&D, Inc.
Substance NameTELAVANCIN HYDROCHLORIDE
Active Ingredient Strength15 mg/mL
Pharm ClassesLipoglycopeptide Antibacterial [EPC],Lipoglycopeptides [EXT]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC SPL Data Element Entries

NDC 62847-002-01 [62847000201]

Vibativ INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA022110
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-11-05
Marketing End Date2018-02-01

Drug Details

Active Ingredients

IngredientStrength
TELAVANCIN HYDROCHLORIDE15 mg/mL

OpenFDA Data

SPL SET ID:c09655ea-7af5-4443-a769-86e416214f59
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1728089
  • 1728082
  • 1728085
  • 1728087
  • UPC Code
  • 0362847001016
  • Pharmacological Class

    • Lipoglycopeptide Antibacterial [EPC]
    • Lipoglycopeptides [EXT]

    NDC Crossover Matching brand name "Vibativ" or generic name "Telavancin Hydrochloride"

    NDCBrand NameGeneric Name
    52118-001Vibativtelavancin hydrochloride
    52118-002Vibativtelavancin hydrochloride
    62847-001Vibativtelavancin hydrochloride
    62847-002Vibativtelavancin hydrochloride
    66220-315VIBATIVtelavancin hydrochloride

    Trademark Results [Vibativ]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    VIBATIV
    VIBATIV
    79035545 3939879 Live/Registered
    Cumberland Pharmaceuticals Inc.
    2007-01-22

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.